(NASDAQ: CMRA) Engineering superior biotherapeutic formulations for fragile patients.
Location: United States, Massachusetts, Woburn
Investors 1
| Date | Name | Website |
| - | Phoenix Ve... | phoenix-vp... |
Mentions in press and media 4
| Date | Title | Description |
| 04.01.2023 | Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules | /EIN News/ -- WOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, a... |
| 04.01.2023 | Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules | - |
| 04.02.2022 | OTR Acquisition : Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination - Form 8-K | OTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination Investor Call Rescheduled to Tuesday, Feb. 8 at 8:30 a.m. EST to Discuss Combination between Comera Life Sciences... |
| 31.01.2022 | OTR Acquisition : Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp - Form 8-K | Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp. · Comera Life Sciences is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience... |